Eris Lifesciences’s Q2FY23 revenue up 28 per cent YoY
EBITDA at Rs 1,514 million, with 32.9 per cent EBITDA margin; PAT stood at Rs 1,194 million, with 25.9 per cent PAT margin
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
financial result
Torrent Pharma December quarter profit slips 16 per cent to Rs 249 crores
The drugmaker had posted a net profit of Rs 297 crores in the October-December period of the 2020-21 fiscal